As caspase-3 and -7 are the final executioners of apoptosis, both inhibition and activation of catalytic activities are of significant interest as therapeutic strategies for neurodegenerative diseases and cancers [5,15-18]. This evidence concerns the gene CASP3 and neurodegenerative disease.